These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

709 related articles for article (PubMed ID: 12478295)

  • 21. Effect of antibody valency on interaction with cell-surface expressed HIV-1 and viral neutralization.
    Cavacini LA; Emes CL; Power J; Duval M; Posner MR
    J Immunol; 1994 Mar; 152(5):2538-45. PubMed ID: 7510748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the multiple conformational States of free monomeric and trimeric human immunodeficiency virus envelope glycoproteins after fixation by cross-linker.
    Yuan W; Bazick J; Sodroski J
    J Virol; 2006 Jul; 80(14):6725-37. PubMed ID: 16809278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted deletion in the beta20-beta21 loop of HIV envelope glycoprotein gp120 exposes the CD4 binding site for antibody binding.
    Berkower I; Patel C; Ni Y; Virnik K; Xiang Z; Spadaccini A
    Virology; 2008 Aug; 377(2):330-8. PubMed ID: 18519142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV vaccine design and the neutralizing antibody problem.
    Burton DR; Desrosiers RC; Doms RW; Koff WC; Kwong PD; Moore JP; Nabel GJ; Sodroski J; Wilson IA; Wyatt RT
    Nat Immunol; 2004 Mar; 5(3):233-6. PubMed ID: 14985706
    [No Abstract]   [Full Text] [Related]  

  • 25. The prolonged culture of human immunodeficiency virus type 1 in primary lymphocytes increases its sensitivity to neutralization by soluble CD4.
    Pugach P; Kuhmann SE; Taylor J; Marozsan AJ; Snyder A; Ketas T; Wolinsky SM; Korber BT; Moore JP
    Virology; 2004 Mar; 321(1):8-22. PubMed ID: 15033560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective recognition of oligomeric HIV-1 primary isolate envelope glycoproteins by potently neutralizing ligands requires efficient precursor cleavage.
    Pancera M; Wyatt R
    Virology; 2005 Feb; 332(1):145-56. PubMed ID: 15661147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a novel CD4i human monoclonal antibody Fab that neutralizes HIV-1 primary isolates from different clades.
    Zhang MY; Shu Y; Sidorov I; Dimitrov DS
    Antiviral Res; 2004 Mar; 61(3):161-4. PubMed ID: 15168796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV-1 neutralization by chimeric CD4-CG10 polypeptides fused to human IgG1.
    Meyuhas R; Noy H; Montefiori DC; Denisova G; Gershoni JM; Gross G
    Mol Immunol; 2005 May; 42(9):1099-109. PubMed ID: 15829299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody and HIV-1 gp120 recognition of CD4 undermines the concept of mimicry between antibodies and receptors.
    Davis SJ; Schockmel GA; Somoza C; Buck DW; Healey DG; Rieber EP; Reiter C; Williams AF
    Nature; 1992 Jul; 358(6381):76-9. PubMed ID: 1614536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of human immunodeficiency virus type 1 monomeric and trimeric gp120 glycoproteins stabilized in the CD4-bound state: antigenicity, biophysics, and immunogenicity.
    Dey B; Pancera M; Svehla K; Shu Y; Xiang SH; Vainshtein J; Li Y; Sodroski J; Kwong PD; Mascola JR; Wyatt R
    J Virol; 2007 Jun; 81(11):5579-93. PubMed ID: 17360741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conformational and structural features of HIV-1 gp120 underlying the dual receptor antagonism by cross-reactive neutralizing antibody m18.
    Gift SK; Zentner IJ; Schön A; McFadden K; Umashankara M; Rajagopal S; Contarino M; Duffy C; Courter JR; Zhang MY; Gershoni JM; Cocklin S; Dimitrov DS; Smith AB; Freire E; Chaiken IM
    Biochemistry; 2011 Apr; 50(14):2756-68. PubMed ID: 21351734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01.
    Zhou T; Georgiev I; Wu X; Yang ZY; Dai K; Finzi A; Kwon YD; Scheid JF; Shi W; Xu L; Yang Y; Zhu J; Nussenzweig MC; Sodroski J; Shapiro L; Nabel GJ; Mascola JR; Kwong PD
    Science; 2010 Aug; 329(5993):811-7. PubMed ID: 20616231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rational design of a CD4 mimic that inhibits HIV-1 entry and exposes cryptic neutralization epitopes.
    Martin L; Stricher F; Missé D; Sironi F; Pugnière M; Barthe P; Prado-Gotor R; Freulon I; Magne X; Roumestand C; Ménez A; Lusso P; Veas F; Vita C
    Nat Biotechnol; 2003 Jan; 21(1):71-6. PubMed ID: 12483221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NMR study and comparison of the antigenic properties of a peptide recognized by two HIV-1 neutralizing antibodies.
    Tsang P; Mu X; Wu G; Durda PJ
    J Mol Recognit; 1997; 10(6):256-61. PubMed ID: 9770649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. gp120: Biologic aspects of structural features.
    Poignard P; Saphire EO; Parren PW; Burton DR
    Annu Rev Immunol; 2001; 19():253-74. PubMed ID: 11244037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A modeled structure of an aptamer-gp120 complex provides insight into the mechanism of HIV-1 neutralization.
    Joubert MK; Kinsley N; Capovilla A; Sewell BT; Jaffer MA; Khati M
    Biochemistry; 2010 Jul; 49(28):5880-90. PubMed ID: 20527993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neutralization of divergent HIV-1 isolates by conformation-dependent human antibodies to Gp120.
    Steimer KS; Scandella CJ; Skiles PV; Haigwood NL
    Science; 1991 Oct; 254(5028):105-8. PubMed ID: 1718036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody binding is a dominant determinant of the efficiency of human immunodeficiency virus type 1 neutralization.
    Yang X; Lipchina I; Cocklin S; Chaiken I; Sodroski J
    J Virol; 2006 Nov; 80(22):11404-8. PubMed ID: 16956933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enzymatic labeling of biologically active envelope glycoprotein gp120 of HIV-1.
    Berkower I; Murphy D
    Biochem Biophys Res Commun; 1993 Mar; 191(3):1055-65. PubMed ID: 8466484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neutralization of divergent HIV-1 isolates by conformation dependent human antibodies to gp120.
    Dis Markers; 1991; 9(6):344-5. PubMed ID: 1823318
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.